Amneal Pharmaceuticals, Inc. affirmed earnings guidance for full year 2024. For the year, company expects Net revenue to be $2.55 billion - $2.65 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.75 USD | +0.90% | +1.05% | +11.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.20% | 2.08B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024